Related references
Note: Only part of the references are listed.Colorectal cancer: a tale of two sides or a continuum?
Mai Yamauchi et al.
GUT (2012)
Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum
Mai Yamauchi et al.
GUT (2012)
Clinical characterization of patients with metastatic colorectal cancer depending on the KRAS status
Dominik P. Modest et al.
ANTI-CANCER DRUGS (2011)
iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis
Kai-Cheng Hsu et al.
BMC BIOINFORMATICS (2011)
KRAS, BRAF, EGFR and HER2 gene status in a Spanish population of colorectal cancer
Marta Herreros-Villanueva et al.
MOLECULAR BIOLOGY REPORTS (2011)
Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
Wendy De Roock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
(PS)2-v2: template-based protein structure prediction server
Chih-Chieh Chen et al.
BMC BIOINFORMATICS (2009)
Genotyping of K-ras codons 12 and 13 mutations in colorectal cancer by capillary electrophoresis
Yen-Ling Chen et al.
JOURNAL OF CHROMATOGRAPHY A (2009)
American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy
David Z. Chang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2009)
Implications for KRAS status and EGFR-targeted therapies in metastatic CRC
Nicola Normanno et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer
Jens Neumann et al.
PATHOLOGY RESEARCH AND PRACTICE (2009)
Determinants of RASistance to anti-epidermal growth factor receptor agents
Jose Baselga et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab
Astrid Lievre et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
Rafael G. Amado et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
K-ras mutations and benefit from cetuximab in advanced colorectal cancer
Christos S. Karapetis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab
W. De Roock et al.
ANNALS OF ONCOLOGY (2008)
Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy
F. Di Fiore et al.
BRITISH JOURNAL OF CANCER (2007)
Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies
Silvia Benvenuti et al.
CANCER RESEARCH (2007)
Recurrent KRAS Codon 146 mutations in human colorectal cancer
Sarah Edkins et al.
CANCER BIOLOGY & THERAPY (2006)
(PS)2:: protein structure prediction server
Chih-Chieh Chen et al.
NUCLEIC ACIDS RESEARCH (2006)
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer
A Lièvre et al.
CANCER RESEARCH (2006)
GROMACS: Fast, flexible, and free
D Van der Spoel et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study
M Moroni et al.
LANCET ONCOLOGY (2005)
Oligonucleotide microarray-based mutation detection of the K-ras gene in colorectal cancers with use of competitive DNA hybridization
JH Park et al.
CLINICAL CHEMISTRY (2004)
PRODRG:: a tool for high-throughput crystallography of protein-ligand complexes
AW Schüttelkopf et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
GEMDOCK: A generic evolutionary method for molecular docking
JM Yang et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study
M Brink et al.
CARCINOGENESIS (2003)
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype
V Bazan et al.
ANNALS OF ONCOLOGY (2002)
Molecular dynamics simulations of Gly-12→Val mutant of p21ras:: Dynamic inhibition mechanism
N Futatsugi et al.
BIOPHYSICAL JOURNAL (2001)
Protein thermal stability: insights from atomic displacement parameters (B values)
S Parthasarathy et al.
PROTEIN ENGINEERING (2000)
Share Paper
